VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $579,127 | -34.9% | 52,315 | -4.7% | 0.00% | – |
| Q2 2023 | $889,475 | +63.8% | 54,872 | +68.3% | 0.00% | – |
| Q1 2023 | $542,873 | +32.3% | 32,605 | -25.3% | 0.00% | – |
| Q4 2022 | $410,310 | +279.9% | 43,650 | +10.2% | 0.00% | – |
| Q3 2022 | $108,000 | -6.1% | 39,619 | -0.2% | 0.00% | – |
| Q2 2022 | $115,000 | +47.4% | 39,693 | +51.8% | 0.00% | – |
| Q1 2022 | $78,000 | -38.6% | 26,151 | -5.0% | 0.00% | – |
| Q4 2021 | $127,000 | -37.4% | 27,516 | -15.0% | 0.00% | – |
| Q3 2021 | $203,000 | +26.1% | 32,365 | +20.3% | 0.00% | – |
| Q2 2021 | $161,000 | 0.0% | 26,895 | +5.9% | 0.00% | – |
| Q1 2021 | $161,000 | +98.8% | 25,395 | +76.4% | 0.00% | – |
| Q4 2020 | $81,000 | -3.6% | 14,395 | 0.0% | 0.00% | – |
| Q3 2020 | $84,000 | -36.8% | 14,395 | -21.7% | 0.00% | – |
| Q2 2020 | $133,000 | +9.0% | 18,395 | -29.6% | 0.00% | – |
| Q1 2020 | $122,000 | -14.1% | 26,120 | +47.8% | 0.00% | – |
| Q4 2019 | $142,000 | -3.4% | 17,670 | -17.3% | 0.00% | – |
| Q3 2019 | $147,000 | +2.8% | 21,368 | +24.3% | 0.00% | – |
| Q2 2019 | $143,000 | -90.1% | 17,185 | -88.2% | 0.00% | -100.0% |
| Q1 2019 | $1,449,000 | – | 145,785 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |